Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
DIAMOX 250mg Tablets.
Acetazolamide Mercury Pharma 250mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Round, convex, white tablets engraved with “FW 147” on one side and cored in quarters on the other. |
Each tablet contains 250mg acetazolamide BP.
For excipients see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acetazolamide |
Acetazolamide is an enzyme inhibitor which acts specifically on carbonic anhydrase. By inhibiting the reaction catalysed by this enzyme in the renal tubules, acetazolamide increases the excretion of bicarbonate and of cations, chiefly sodium and potassium, and so promotes alkaline diuresis. By inhibiting carbonic anhydrase in the eye acetazolamide decreases intra-ocular pressure and is therefore useful in the treatment of glaucoma. |
| List of Excipients |
|---|
|
Dicalcium phosphate |
Amber glass bottles with metal screw-on caps.
Polypropylene bottles with plastic screw-on caps.
The product is supplied in bottles of 112 tablets.
Mercury Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 12762/0147
12/12/2003
| Drug | Countries | |
|---|---|---|
| DIAMOX | Austria, Australia, Brazil, Estonia, France, Croatia, Ireland, Japan, Netherlands, New Zealand, Tunisia, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
